Clinical evaluation of the safety of robotic gastrectomy using da Vinci surgical system (DVSS) for resectable gastric cancer

Clinical evaluation of the safety of robotic gastrectomy using da Vinci surgical system (DVSS) for resectable gastric cancer - Clinical evaluation of the safety of robotic gastrectomy for gastric cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000019366

Enrollment

Registered

2015-10-15

Start date

2015-10-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer

Interventions

Robotic surgery

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Histologically diagnosed gastric adenocarcionoma 2) cStage I, II or III disease curably treated with total, proximal, or distal gastrectomy with lymph node dissection 3) Not indicated for endoscopic resection 4) Age over 18 5) Informed consent is obtained

Exclusion criteria

Exclusion criteria: 1) Patients with psychiatric or mental disorders 2) Preoperative use of chemotherapy 3) Possibly pregnant, or breast feeding woman 4) Receiving steroids 5) Paticents with acute myocardial infaction in 6 months or with unstable ungina 6) Patients with pulmonary disease and require continuous oxygen therapy

Design outcomes

Primary

Measure	Time frame
The incidence of post-operative complications during one month after surgery.	—

Secondary

Measure	Time frame
Completion rate of robot assised surgery The incidence of adverse event	—

Countries

Japan

Contacts

Public ContactYoshihiro Hiramatsu

Hamamatsu University School of Medicine Department of Surgery

hiramatu@hama-med.ac.jp053-435-2279

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026